| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/23/2002 | US6375945 Qs-21 and qs-17, 3-o-deacylated monophosphoryl lipid a and interleukin 12, where qs-21 and qs-17 are derived from the bark of the south american tree quillaja saponaria molina |
| 04/23/2002 | CA2099771C Liposomal-polyene preliposomal powder and method for its preparation |
| 04/23/2002 | CA2032261C Antiviral polyheterocyclic dimers |
| 04/18/2002 | WO2002031511A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 04/18/2002 | WO2002031498A2 Protecting therapeutic compositions from host-mediated inactivation |
| 04/18/2002 | WO2002031156A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031110A2 Hematopoietic stem cell gene therapy |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030983A2 Plasma fraction containing bikunin, method for the production thereof and use of the same |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 04/18/2002 | WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | WO2002030905A1 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 04/18/2002 | WO2002030901A1 Process for making 3-amino-2-chloro-4-methylpyridine |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030884A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030882A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030876A2 Cyclic carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030863A2 Ether compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030458A1 Yersinia adhesion protein as vaccine adjuvant |
| 04/18/2002 | WO2002030455A2 Agents for the treatment of viral infections |
| 04/18/2002 | WO2002030453A1 Methods of inhibiting angiogenesis using nadph oxidase inhibitors |
| 04/18/2002 | WO2002030435A1 Treatment of t cell disorders |
| 04/18/2002 | WO2002030434A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/18/2002 | WO2002030426A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030423A1 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030410A2 Suppression of cyclin kinase activity for prevention and treatment of infections |
| 04/18/2002 | WO2002030396A1 Medication delivery devices |
| 04/18/2002 | WO2002030395A1 Topical antibiotic composition for treatment of eye infection |
| 04/18/2002 | WO2002030392A2 Formulation containing amoxicillin |
| 04/18/2002 | WO2002030353A2 NF-λB INHIBITORS |
| 04/18/2002 | WO2002030320A2 Stimulation of thymus for vaccination development |
| 04/18/2002 | WO2002030259A2 Disease prevention by reactivation of the thymus |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002011742A3 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 04/18/2002 | WO2002011740A3 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 04/18/2002 | WO2002009749A3 Respiratory syncytial virus vaccine |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2002007760A3 Therapeutic agent against aids comprising anti hiv goat antibody |
| 04/18/2002 | WO2002007742A9 Bacteriophage having multiple host range |
| 04/18/2002 | WO2002007721A3 Use of cox-2 inhibitors for preventing immunodeficiency |
| 04/18/2002 | WO2002000201A3 Method for preparing a composition |
| 04/18/2002 | WO2002000163A3 The method of treating drug resistant mycobacterium tuberculosis infection |
| 04/18/2002 | WO2001096353A3 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 04/18/2002 | WO2001087229A3 Treating infections |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001070247A3 Salmonella vaccine materials and methods |
| 04/18/2002 | WO2001070209A3 Mono- and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001064752A3 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 04/18/2002 | WO2001060378A3 Antiadhesive carbohydrates |
| 04/18/2002 | WO2001060345A3 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2001058483A3 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 04/18/2002 | WO2001054718A3 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions |
| 04/18/2002 | WO2001053330A3 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 04/18/2002 | WO2001051080A3 Methods and compositions for obtaining disease protection for animals |
| 04/18/2002 | WO2001045691A3 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 04/18/2002 | WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/18/2002 | WO2000068387A9 Nucleic acids and proteins with interferon-beta activity |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045645 Lactone integrin antagonists |
| 04/18/2002 | US20020045635 Novel mGluR antagonists and a method for their synthesis |
| 04/18/2002 | US20020045625 Oxazolidinone chemotherapeutic agents |
| 04/18/2002 | US20020045623 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 04/18/2002 | US20020045619 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 04/18/2002 | US20020045613 1-aroyl-piperidinyl benzamidines |
| 04/18/2002 | US20020045602 7-substituted fused ring tetracycline compounds |
| 04/18/2002 | US20020045586 Mono-and disaccharides for the treatment of nitric oxide related disorders |
| 04/18/2002 | US20020045574 Vancomycin analogs having improved activity against bacterial infection |
| 04/18/2002 | US20020045568 Use of mp52 0r mp121 for treating and preventing diseases of the nervous system |
| 04/18/2002 | US20020045222 Compositions and methods for saccharide synthesis |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045203 Method for detecting active ingredients of medical value |
| 04/18/2002 | US20020045162 Identification of viral agents in breast ducts and antiviral therapy therefore |
| 04/18/2002 | US20020044972 Nucleic acid or oligonucleotide and a positively charged, aminated ethylene oxide-propylene oxide block copolymer |
| 04/18/2002 | US20020044967 Sustained release preparations |
| 04/18/2002 | US20020044965 Side effect profile reduction |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044929 Methods for treating sepsis |